Blog - AiFChem

Recently Added

No recently added products.

Only display the lastest 5 added Cart

Antibody-Drug Conjugates: From Basic Principles to the Latest Drug LandscapeSeptember 18, 2026

ADC

Author: AiFChem

Comment: 0

The mRNA Paradigm: From Infectious Disease to Precision OncologySeptember 4, 2026

mRNA

Author: AiFChem

Comment: 0

Unlocking Chiral Amino Alcohols: Next-Gen Antimony Catalysis for Accelerated Drug DiscoveryAugust 20, 2026

Methodology

Author: AiFChem

Comment: 0

Optimization of CRBN Ligand and Linker Drives Discovery of APH003, an Orally Bioavailable IRAK4 PROTAC DegraderAugust 11, 2026

Author: AiFChem

Comment: 0

Metal-Free Alkynyl Boron Platform for Modular Synthesis of Stereodefined AllylaminesAugust 4, 2026

Methodology

Author: AiFChem

Comment: 0

Targeting ERAP1: The Discovery and Optimization of Allosteric Inhibitor GSK235August 4, 2026

Author: AiFChem

Comment: 0

Discovery of SD-2301: A Single-Dose VHL-Recruiting STAT3 PROTAC DegraderAugust 1, 2026

Author: AiFChem

Comment: 0

tert-Butyl Group in Drug Design: Metabolic Liabilities and Bioisosteric StrategiesJune 11, 2026

Author: AiFChem

Comment: 0

Unlocking Direct C–S Bonds: Radical C–SuFEx Ligation of Sulfonyl and Sulfonimidoyl Fluorides with Alkenes and AlkynesJune 2, 2026

Methodology

Author: AiFChem

Comment: 0

Oxetane as a Strategic Bioisostere: Improving ADMET Profiles and Pharmacokinetics in Small Molecule DesignMay 29, 2026

Author: AiFChem

Comment: 0

Gesamt: 88

…